Par Pharmaceutical Companies, Inc. is a privately held, U.S.-based specialty pharmaceutical company that develops, manufactures and markets high-barrier-to-entry generic drugs and niche, innovative proprietary pharmaceuticals through its wholly-owned subsidiary’s two operating divisions, Par Pharmaceutical and Strativa Pharmaceuticals. Par is a portfolio company of TPG, a leading global private investment firm with $55.7 billion of assets under management and with extensive experience in the healthcare sector.
The following is the list of scholars from PAR Sterile Products who currently serve as editors for one or more SciTechnol journals.
The following is the list of articles by scholars from PAR Sterile Products that are published in SciTechnol journals.
- Editorial: J Pharm Drug Deliv Res 2017, 6:6
An Observation on Vancomycin Concentrations in Cerebrospinal Fluid and Serum of a Chinese Critically-Ill Patient with Intravenous Drug InjectionCase Report: J Pharm Drug Deliv Res 2017, 6:6
Mo-Han Dong, Ying Wu, Bei-Yu Chen and Ai-Dong Wen
- Research Article: J Pharm Drug Deliv Res 2017, 6:6
Abdullah Alomrani, Samiah Alhabardi, Abdelilah Aboussekhra, Aws Alshamsan, Bushra Al Quadeib
- Research Article: J Pharm Drug Deliv Res 2018, 6:6
Eliphaz Mukasa and Danckwerts PM
- Review Article: J Pharm Drug Deliv Res 2018, 6:6
A Validated RP-HPLC Method for the Simultaneous Determination of Six High-Boiling Residual Solvents in Drug Substances and Its Implementation in ApisShort Article: J Pharm Drug Deliv Res 2017, 6:6
Gangrade MG, Deshpande NM, Gharat HP*, More SD, Shinde SS, Raval VK, Sapre JV and Alexander RT